Market Segmentation Tab
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Regional Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
 Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
 Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Â
Â
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Medical Marijuana Product Type Outlook (USD Billion, 2018-2030)
Medical Marijuana Application Outlook (USD Billion, 2018-2030)
Medical Marijuana Distribution Channel Outlook (USD Billion, 2018-2030)
Â
Research Methodology on Medical Marijuana Market
Introduction:
Medical Marijuana is a relatively new and emerging concept in the medical field. As such, there is a pressing need for more research and study into the potential applications and uses of this form of medication. Medical marijuana has been used to treat a variety of medical conditions such as PTSD, anxiety, chronic pain, and epilepsy. There is however a need to further explore the efficacy, safety and side-effects of medical marijuana use, as well as the market dynamics that support its use, such as laws and regulations, and the economic factors influencing its implementation. The research report published by Market Research Future (MRFR) goes some way to identify the existing trends in the Medical Marijuana market, as well as providing projections of the likely developments in this sector over the forecast period from 2023 to 2030.
This research methodology aims to inform the research design and analytical methods required to construct an in-depth analysis of Medical Marijuana use, in the context of the current market environment surrounding it. This accordingly explains the different components of the research process and the role that each component will play in conducting a comprehensive research study. More concretely, it will explicate the research structure, data collection methods, sample selection and data analysis techniques to be used for this research project.
Research Structure:
The research design for the Medical Marijuana Market Report combines both quantitative and qualitative research approaches. Firstly, an extensive literature review is conducted, to acquire baseline knowledge of the current field of Medical Marijuana, such as its applications, safety and efficacy. The information gathered is used to formulate an appropriate research structure and suitable research questions.
The quantitative component of the research provides a comprehensive overview of the Medical Marijuana Market, assessing the existing and projected trends in the field. Survey questionnaires are employed to gather primary data from market players, experts, and consumer representative groups. The data collected is then analyzed in order to identify patterns, trends, and correlations between different variables. The quantitative component of the research is expected to produce outcomes that are used in the analysis of the economic and legal factors influencing the Medical Marijuana market.
The qualitative component of the research adopts an exploratory approach, utilizing semi-structured interviews with key stakeholders to gain a deeper understanding of the attitudes and perceptions about using Medical Marijuana in the market. The exploitation of this form of data is used to assess the social and psychological implications of using Medical Marijuana, as well as the potential issues faced by patients taking this medication. The qualitative component of the research is expected to illuminate the true potential and limitations of Medical Marijuana use.
Data Collection and Sample Selection Methods:
The primary data collection approach for this research report involves a combination of surveys, interviews, and consumer focus groups. The survey part of the research follows a closed-ended approach, as this method allows for ease of comparison and analysis. The survey questionnaire includes questions related to the current market dynamics of medical marijuana, as well as attitudes and beliefs towards its use.
The interview and consumer focus group parts of the research follow an open-ended approach, to draw out a deeper understanding of Medical Marijuana use. For the interview stage, the target population include market players, medical experts, and patient groups. For the sample selection process, a stratified sampling method is used to acquire diverse demographic representation in our results.
Data Analysis:
The data collected is analyzed using both descriptive and inferential statistical techniques. The descriptive techniques involve using basic summative figures and graphs to summarize the data. The inferential techniques involve the use of more complex analytical approaches such as regression analyses, ANOVA tests, and covariance tests. These techniques allow us to assess the extent of relationships, causalities and progression between different variables in the data set. The analytical techniques used for this project will produce the necessary outcomes to inform both the quantitative and qualitative assessment of the Medical Marijuana Market.
Conclusion:
This research methodology outlines the appropriate research design and data collection methods to be adopted for the Medical Marijuana Market Report. A combination of quantitative and qualitative research approaches will be necessary in order to construct a comprehensive analysis of the current and future market dynamics of medical marijuana use. The data collected is analyzed using a combination of both descriptive and inferential statistical techniques. The outcomes of the research are expected to provide a comprehensive understanding of the existing and upcoming trends in Medical Marijuana, as well as provide insights into the economic, legal and social implications of its use.
1 Report Prologue
2 Market Introduction
2.1 Scope of Study 14
2.2 Research Objective 14
2.3 List of Assumptions 14
3 Research Methodology
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamics
4.1 Introduction 22
4.2 Drivers 22
4.2.1 Growing research and development activities and financial support by various private and
government organizations for cannabinoid research 22
4.2.2 Rising prevalence of chronic diseases and other medical conditions 22
4.2.3 Increasing authorization of marijuana for medical applications 22
4.3 Restraints 23
4.3.1 Stringent government policies 23
4.3.2 Increasing illegal use of marijuana 23
4.3.3 Side-effects after the intense use of marijuana 23
4.4 Challenges 23
4.4.1 Change in government regulations for the use of cannabis for medical applications 23
5 Market Factor Analysis
5.1 Value Chain Analysis 25
5.1.1 Overview 25
5.1.2 R&D 25
5.1.3 Manufacturing 25
5.1.4 Distribution & Sales 25
5.1.5 Post-Sales Monitoring 26
5.2 Porter’s Five Forces Model 26
5.2.1 Overview 26
5.2.2 Bargaining Power of Suppliers 27
5.2.3 Bargaining Power of Buyers 27
5.2.4 Threat of New Entrants 27
5.2.5 Threat of Substitutes 27
5.2.6 Intensity of Rivalry 27
6 Global Medical Marijuana Market, by Product Type
6.1 Introduction 29
6.2 Solids 31
6.3 Dissolvables/Powders 31
6.4 Oil 32
6.5 Ointments & Creams 32
7 Global Medical Marijuana Market, by Application
7.1 Introduction 34
7.2 Alzheimer’s Disease 35
7.3 Cancer 36
7.4 Schizophrenia 36
7.5 Multiple Sclerosis 37
8 Global Medical Marijuana Market, by Distribution Channel
8.1 Introduction 39
8.2 Retail & Pharmacy Stores 40
8.3 Online Platforms 41
9 Global Medical Marijuana Market, by Region
9.1 Introduction 43
9.2 Americas 44
9.2.1 North America 46
9.2.1.1 US 49
9.2.1.2 Canada 50
9.2.2 South America 52
9.3 Europe 54
9.3.1 Western Europe 56
9.3.1.1 Germany 59
9.3.1.2 UK 60
9.3.1.3 France 62
9.3.1.4 Italy 63
9.3.1.5 Spain 65
9.3.1.6 Rest of Western Europe 66
9.3.2 Eastern Europe 68
9.4 Asia-Pacific 70
9.4.1 Japan 72
9.4.2 China 74
9.4.3 India 75
9.4.4 Australia 77
9.4.5 Republic of Korea 78
9.4.6 Rest of Asia-Pacific 80
9.5 Rest of the World 82
10 Competitive Landscape
11 Company Profile
11.1 Canopy Growth Corporation 87
11.1.1 Company Overview 87
11.1.2 Financial Overview 87
11.1.3 Products/Services Offered 87
11.1.4 Key Developments 88
11.1.5 SWOT Analysis 88
11.1.6 Key Strategy 88
11.2 Cannabis Sativa Inc. 89
11.2.1 Company Overview 89
11.2.2 Financial Overview 89
11.2.3 Products/Services Offered 89
11.2.4 Key Developments 90
11.2.5 SWOT Analysis 90
11.2.6 Key Strategy 90
11.3 GW Pharmaceuticals Plc 91
11.3.1 Company Overview 91
11.3.2 Financial Overview 91
11.3.3 Products/Services Offered 92
11.3.4 Key Developments 92
11.3.5 SWOT Analysis 92
11.3.6 Key Strategy 92
11.4 Emerald Health Therapeutics Inc. 93
11.4.1 Company Overview 93
11.4.2 Financial Overview 93
11.4.3 Products/Services Offered 94
11.4.4 Key Developments 94
11.4.5 SWOT Analysis 94
11.4.6 Key Strategy 95
11.5 Tilray 96
11.5.1 Company Overview 96
11.5.2 Financial Overview 96
11.5.3 Products/Services Offered 97
11.5.4 Key Developments 97
11.5.5 SWOT Analysis 97
11.5.6 Key Strategy 98
11.6 Aphria 99
11.6.1 Company Overview 99
11.6.2 Financial Overview 99
11.6.3 Products/Services Offered 100
11.6.4 Key Developments 100
11.6.5 SWOT Analysis 100
11.6.6 Key Strategy 100
11.7 CanniMed Ltd 101
11.7.1 Company Overview 101
11.7.2 Financial Overview 101
11.7.3 Products/Services Offered 101
11.7.4 Key Developments 101
11.7.5 SWOT Analysis 102
11.7.6 Key Strategy 102
11.8 Cara Therapeutics 103
11.8.1 Company Overview 103
11.8.2 Financial Overview 103
11.8.3 Pipeline Products 103
11.8.4 Key Developments 103
11.8.5 SWOT Analysis 104
11.8.6 Key Strategy 104
11.9 Pfizer Inc. 105
11.9.1 Company Overview 105
11.9.2 Financial Overview 105
11.9.3 Clinical Trial Products 106
11.9.4 Key Developments 106
11.9.5 SWOT Analysis 106
11.9.6 Key Strategy 106
11.10 Medical Marijuana Inc. 107
11.10.1 Company Overview 107
11.10.2 Financial Overview 107
11.10.3 Products/Services Offered 107
11.10.4 Key Developments 107
11.10.5 SWOT Analysis 108
11.10.6 Key Strategy 108
11.11 GBSciences Inc. 109
11.11.1 Company Overview 109
11.11.2 Financial Overview 109
11.11.3 Pipeline Products 109
11.11.4 Key Developments 109
11.11.5 SWOT Analysis 109
11.11.6 Key Strategy 110
11.12 MediPharm Labs 111
11.12.1 Company Overview 111
11.12.2 Financial Overview 111
11.12.3 Products/Services Offered 111
11.12.4 Key Developments 111
11.12.5 SWOT Analysis 111
11.12.6 Key Strategy 112
12 Appendix
12.1 Discussion Blue Print 114
13 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 14
TABLE 2 PRIMARY INTERVIEWS 17
TABLE 3 GLOBAL MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 30
TABLE 4 GLOBAL MARKET BY REGION, FOR SOLIDS 2020–2027 (USD MILLION) 31
TABLE 5 GLOBAL: MARKET BY REGION, FOR DISSOLVABLES/POWDERS 2020–2027 (USD MILLION) 31
TABLE 6 GLOBAL: MARKET BY REGION, FOR OIL 2020–2027 (USD MILLION) 32
TABLE 7 GLOBAL: MARKET BY REGION, FOR OINTMENTS & CREAMS 2020–2027 (USD MILLION) 32
TABLE 8 GLOBAL: MARKET BY APPLICATION 2020–2027 (USD MILLION) 34
TABLE 9 GLOBAL: MARKET BY REGION, FOR ALZHEIMER’S DISEASE 2020–2027 (USD MILLION) 35
TABLE 10 GLOBAL: MARKET BY REGION, FOR CANCER 2020–2027 (USD MILLION) 36
TABLE 11 GLOBAL: BY REGION, FOR SCHIZOPHRENIA 2020–2027 (USD MILLION) 36
TABLE 12 GLOBAL: BY REGION, FOR MULTIPLE SCLEROSIS 2020–2027 (USD MILLION) 37
TABLE 13 GLOBAL: BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 39
TABLE 14 GLOBAL: BY REGION, FOR RETAIL & PHARMACY STORES 2020–2027 (USD MILLION) 40
TABLE 15 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR ONLINE PLATFORMS 2020–2027 (USD MILLION) 41
TABLE 16 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION 2020–2027 (USD MILLION) 43
TABLE 17 AMERICAS: MEDICAL MARIJUANA MARKET BY REGION 2020–2027 (USD MILLION) 44
TABLE 18 AMERICAS: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 45
TABLE 19 AMERICAS: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 45
TABLE 20 AMERICAS: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 46
TABLE 21 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY COUNTRY 2020–2027 (USD MILLION) 46
TABLE 22 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 47
TABLE 23 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 48
TABLE 24 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 48
TABLE 25 US: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 49
TABLE 26 US: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 49
TABLE 27 US: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 50
TABLE 28 CANADA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 50
TABLE 29 CANADA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 51
TABLE 30 CANADA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 51
TABLE 31 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 52
TABLE 32 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 52
TABLE 33 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 53
TABLE 34 EUROPE: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2020–2027 (USD MILLION) 54
TABLE 35 EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 55
TABLE 36 EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 55
TABLE 37 EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 56
TABLE 38 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2020–2027 (USD MILLION) 56
TABLE 39 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 57
TABLE 40 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 58
TABLE 41 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 58
TABLE 42 GERMANY: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 59
TABLE 43 GERMANY: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 59
TABLE 44 GERMANY: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 60
TABLE 45 UK: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 60
TABLE 46 UK: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 61
TABLE 47 UK: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 61
TABLE 48 FRANCE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 62
TABLE 49 FRANCE: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 62
TABLE 50 FRANCE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 63
TABLE 51 ITALY: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 63
TABLE 52 ITALY: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 64
TABLE 53 ITALY: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 64
TABLE 54 SPAIN: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 65
TABLE 55 SPAIN: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 65
TABLE 56 SPAIN: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 66
TABLE 57 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 66
TABLE 58 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 67
TABLE 59 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 67
TABLE 60 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 68
TABLE 61 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 68
TABLE 62 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 69
TABLE 63 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2020–2027 (USD MILLION) 70
TABLE 64 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 71
TABLE 65 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 71
TABLE 66 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 72
TABLE 67 JAPAN: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 72
TABLE 68 JAPAN: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 73
TABLE 69 JAPAN: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73
TABLE 70 CHINA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 74
TABLE 71 CHINA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 74
TABLE 72 CHINA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 75
TABLE 73 INDIA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 75
TABLE 74 INDIA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 76
TABLE 75 INDIA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76
TABLE 76 AUSTRALIA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 77
TABLE 77 AUSTRALIA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 77
TABLE 78 AUSTRALIA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 78
TABLE 79 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 78
TABLE 80 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 79
TABLE 81 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 79
TABLE 82 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 80
TABLE 83 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 80
TABLE 84 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 81
TABLE 85 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2020–2027 (USD MILLION) 82
TABLE 86 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY APPLICATION 2020–2027 (USD MILLION) 82
TABLE 87 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 83
TABLE 88 GLOBAL MEDICAL MARIJUANA MARKET MAJOR PLAYERS 2020 85
14 List of Figures
FIGURE 1 GLOBAL MARKET: MARKET STRUCTURE 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 20
FIGURE 4 SUPPLY CHAIN: GLOBAL MEDICAL MARIJUANA MARKET 25
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MEDICAL MARIJUANA MARKET 26
FIGURE 6 GLOBAL: MARKET BY PRODUCT TYPE 2020 & 2027 (USD MILLION) 30
FIGURE 7 GLOBAL: MARKET BY APPLICATION 2020 & 2027 (USD MILLION) 35
FIGURE 8 GLOBAL: MARKET BY DISTRIBUTION CHANNEL 2020 & 2027 (USD MILLION) 40
FIGURE 9 GLOBAL: MARKET BY REGION 2020 (%) 44
FIGURE 10 MARKET BY REGION 2020 (%) 44
FIGURE 11 NORTH AMERICA: MARKET BY COUNTRY 2020 (%) 47
FIGURE 12 EUROPE: MARKET BY COUNTRY/REGION 2020 (%) 54
FIGURE 13 WESTERN EUROPE: MARKET BYCOUNTRY/ REGION 2020 (%) 57
FIGURE 14 ASIA-PACIFIC: MARKET BY COUNTRY/REGION 2020 (%) 70
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
